113 related articles for article (PubMed ID: 11731434)
1. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.
Ruehlmann JM; Xiang R; Niethammer AG; Ba Y; Pertl U; Dolman CS; Gillies SD; Reisfeld RA
Cancer Res; 2001 Dec; 61(23):8498-503. PubMed ID: 11731434
[TBL] [Abstract][Full Text] [Related]
2. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.
Xiang R; Lode HN; Dolman CS; Dreier T; Varki NM; Qian X; Lo KM; Lan Y; Super M; Gillies SD; Reisfeld RA
Cancer Res; 1997 Nov; 57(21):4948-55. PubMed ID: 9354462
[TBL] [Abstract][Full Text] [Related]
3. The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.
Imboden M; Murphy KR; Rakhmilevich AL; Neal ZC; Xiang R; Reisfeld RA; Gillies SD; Sondel PM
Cancer Res; 2001 Feb; 61(4):1500-7. PubMed ID: 11245457
[TBL] [Abstract][Full Text] [Related]
4. Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.
Xiang R; Lode HN; Dreier T; Gillies SD; Reisfeld RA
Cancer Res; 1998 Sep; 58(17):3918-25. PubMed ID: 9731503
[TBL] [Abstract][Full Text] [Related]
5. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
[TBL] [Abstract][Full Text] [Related]
6. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
7. T cell memory against colon carcinoma is long-lived in the absence of antigen.
Xiang R; Lode HN; Gillies SD; Reisfeld RA
J Immunol; 1999 Oct; 163(7):3676-83. PubMed ID: 10490962
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects.
Wang YQ; Wada A; Ugai S; Tagawa M
Oncol Rep; 2003; 10(4):909-13. PubMed ID: 12792744
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.
Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM
Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.
Walser TC; Ma X; Kundu N; Dorsey R; Goloubeva O; Fulton AM
J Immunother; 2007; 30(5):490-8. PubMed ID: 17589289
[TBL] [Abstract][Full Text] [Related]
12. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors.
Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM
J Immunother; 2001; 24(2):138-43. PubMed ID: 11265771
[TBL] [Abstract][Full Text] [Related]
13. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9).
Fulkerson PC; Zimmermann N; Brandt EB; Muntel EE; Doepker MP; Kavanaugh JL; Mishra A; Witte DP; Zhang H; Farber JM; Yang M; Foster PS; Rothenberg ME
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1987-92. PubMed ID: 14769916
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.
Bukowski RM; Rayman P; Molto L; Tannenbaum CS; Olencki T; Peereboom D; Tubbs R; McLain D; Budd GT; Griffin T; Novick A; Hamilton TA; Finke J
Clin Cancer Res; 1999 Oct; 5(10):2780-9. PubMed ID: 10537342
[TBL] [Abstract][Full Text] [Related]
16. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
[TBL] [Abstract][Full Text] [Related]
17. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells.
Guo J; Zhang M; Wang B; Yuan Z; Guo Z; Chen T; Yu Y; Qin Z; Cao X
Int J Cancer; 2003 Jan; 103(2):212-20. PubMed ID: 12455035
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.
Xiang R; Silletti S; Lode HN; Dolman CS; Ruehlmann JM; Niethammer AG; Pertl U; Gillies SD; Primus FJ; Reisfeld RA
Clin Cancer Res; 2001 Mar; 7(3 Suppl):856s-864s. PubMed ID: 11300483
[TBL] [Abstract][Full Text] [Related]
20. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
